GLIOBLASTOMAS AND THE DILEMMA OF ITS TREATMENT: A PHILOSOPHICAL PERSPECTIVE
Glioblastomas (GBs) are aggressive brain tumors with limited treatment options, where surgery, radiotherapy (RXT), and chemotherapy (CMT) offer marginal survival benefits. The economic and healthcare system's role in GB treatment, particularly in developing countries, highlights disparities in patient outcomes and challenges in providing appropriate care.
Authors
- Bruno Lima Pessôa (ORCID: https://orcid.org/0000-0002-9772-7649)
- Marco Orsini (ORCID: https://orcid.org/0000-0002-8526-6937)
- Thiago de Mello Tavares (ORCID: https://orcid.org/0009-0003-0641-1871)
- Billy McBenedict (ORCID: https://orcid.org/0000-0002-8987-5545)
- Lorena Adolphsson
- José Geraldo Medeiros Netto (ORCID: https://orcid.org/0009-0001-1040-6456)
- Luciana Armada
Publication Details
- Published
- 2024-12-06
- DOI
- https://doi.org/10.56238/i-cim-082
- Primary Topic
- Ethics in medical practice
- Type
- article
- Field-Weighted Citation Impact
- 0.00